Showing results (91-100 of 215) with videos related to
Sort By:
Pageof 22
AIDS (London, England)|March 19, 2019
Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocationJames B Maurice, Lucy Garvey, Emmanuel A Tsochatzis, et al.International Journal of STD & AIDS|May 12, 2026
British Association of Sexual Health and HIV guidelines on the management of viral hepatitis 2026Lucy Garvey, Sanjay Bhagani, Ranjababu Kulasegaram, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2016
Psychiatric Symptoms in Patients Receiving DolutegravirAnna Fettiplace, Chris Stainsby, Alan Winston, et al.AIDS (London, England)|June 26, 2007
Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistanceMarta Boffito, Alan Winston, Akil Jackson, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2017
Measurement of Retinal Vessels as a Biomarker of Cerebrovascular Aging in Older HIV-Positive Men Compared With ControlsLewis Haddow, Rosanna Laverick, Irene Leung, et al.Journal of Neurovirology|June 6, 2020
Changes in functional connectivity in people with HIV switching antiretroviral therapySofia Toniolo, Mara Cercignani, Borja Mora-Peris, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2007
The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulationAlan Winston, Patrick W G Mallon, Claudette Satchell, et al.HIV Clinical Trials|August 2, 2012
Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopyJaime H Vera, Lucy J Garvey, Joanna M Allsop, et al.AIDS (London, England)|August 1, 2020
Comorbidity indices in people with HIV and considerations for coronavirus disease 2019 outcomesAlan Winston, Davide De Francesco, Frank Post, et al.AIDS (London, England)|February 15, 2021
Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudineMark Nelson, Alan Winston, Andrew Hill, et al.Pageof 22